ReviewThe Lancet regional health. Europe2021
Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.
Review in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Micro-costing analysis of integrating SARS-CoV-2 antigen rapid detection tests into routine health facility services: a comparison of test-all versus screen-and-test models in Cameroon and Kenya.BMJ public health · 2025Article
- Is resistance to Covid-19 vaccination a "problem"? A critical policy inquiry of vaccine mandates for healthcare workers.AIMS public health · 2024Article
- Effects of public-health measures for zeroing out different SARS-CoV-2 variants.Nature communications · 2023Article
- Results from Canton Grisons of Switzerland suggest repetitive testing reduces SARS-CoV-2 incidence (February-March 2021).Scientific reports · 2022Article
- Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework.BMC public health · 2022Article
- Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022Article
- Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools.Nature communications · 2022Article
- Modeling the optimization of COVID-19 pooled testing: How many samples can be included in a single test?Informatics in medicine unlocked · 2022Article
- A rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission.PloS one · 2022Article
- The human factor between airborne pollen concentrations and COVID-19 disease dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Testing at scale during the COVID-19 pandemic.Nature reviews. Genetics · 2021Review
- SARS-CoV-2 screening: effectiveness and risk of increasing transmission.Journal of the Royal Society, Interface · 2021Article
- Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.PLoS biology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.